Papers/PMID:12352035
Glutamine supplementation in serious illness: a systematic review of the evidence.
Critical care medicine2002The record
2 findings · 1 compound · 2 endpoints
What it reported
How to read these marksWhat moved
2 findings
L-glutamine — decreases infectious complication rate
PreliminaryGrade D, Preliminary. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Glutamine supplementation was also associated with a lower rate of infectious complications (RR, 0.81; 95% CI, 0.64-1.00) and a shorter hospital stay (-2.6 days; 95% CI, -4.5 to -0.7).”
Quoted verbatim from Glutamine supplementation in serious illness: a systematic review of the evidence.. - Study
- meta-analysis
- Population
- surgical and critically ill adult patients (pooled meta-analysis of 14 randomised trials, various glutamine doses and routes)
Effect 0.81 risk ratio, 95% CI 0.64 to 1
Glutamine supplementation in serious illness: a systematic review of the evidence.2002PMID:12352035Permalink
L-glutamine — decreases hospital length of stay
PreliminaryGrade D, Preliminary. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Glutamine supplementation was also associated with a lower rate of infectious complications (RR, 0.81; 95% CI, 0.64-1.00) and a shorter hospital stay (-2.6 days; 95% CI, -4.5 to -0.7).”
Quoted verbatim from Glutamine supplementation in serious illness: a systematic review of the evidence.. - Study
- meta-analysis
- Population
- surgical and critically ill adult patients (pooled meta-analysis of 14 randomised trials, various glutamine doses and routes)
Effect -2.6 mean difference, 95% CI -4.5 to -0.7
Glutamine supplementation in serious illness: a systematic review of the evidence.2002PMID:12352035Permalink